55904-83-1

Basic information

• Product Name: 1,2,5-Thiadiazole, 3,4-dimethoxy-, 1,1-dioxide
• Synonyms: 1,2,5-Thiadiazole, 3,4-dimethoxy-, 1,1-dioxide
• CAS NO: 55904-83-1
• Molecular Formula: C₄H₆N₂O₄S
• Molecular Weight: 178
• Mol File: 55904-83-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,2,5-Thiadiazole, 3,4-dimethoxy-, 1,1-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,5-Thiadiazole, 3,4-dimethoxy-, 1,1-dioxide(55904-83-1)
• EPA Substance Registry System: 1,2,5-Thiadiazole, 3,4-dimethoxy-, 1,1-dioxide(55904-83-1)

Safety Data

• Hazardous Substances Data: 55904-83-1(Hazardous Substances Data)

Usage

Structure

Thiazole derivative with two methoxy groups and a dioxide functional group attached to the heterocycle

Potential applications

a. Pharmaceutical industry
b. Agrochemical industry

Uses

a. Synthesis of biologically active molecules
b. Building block for the creation of novel materials with specific properties

Further research

May reveal additional uses and potential benefits of the compound

Upstream product

• 55904-37-5 3,4-dimethoxy-1,2,5-thiadiazole 
• 78441-23-3 3,4-dimethoxy-1,2,5-thiadiazole-1-oxide 
• 67-56-1 methanol 
• 55904-85-3 3,4-dichloro-[1,2,5]thiadiazole 1,1-dioxide 

Downstream Products

• 55904-91-1 4,5,6,7-Tetrahydro-1,2,5-thiadiazol<3,4-b>pyrazin-2,2-dioxid 
• 55904-35-3 1,1-dioxo-1H-1λ⁶-[1,2,5]thiadiazole-3,4-diamine 
• 93364-59-1 3-[3-(N-benzyl-N-(2-pyridyl)amino)propylamino]-4-amino-1,2,5-thiadiazole-1,1-dioxide 
• 1021300-85-5 C₂₆H₂₀N₄O₁₃S₄ 
• 681509-59-1 C₁₂H₁₄N₄O₅S 
• 78441-83-5 3-{2-[(5-dimethylaminomethyl-furan-2-yl)methylthio]ethylamino}-4-amino-1,2,5-thiadiazole 1,1-dioxide 

Relevant articles and documents

AMINE-LINKED PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having th

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).